Pulmonary Disease Platform
WuXi AppTec offers a comprehensive platform of services for pulmonary disease-related research. Our panel of validated disease models covers pulmonary fibrosis, pulmonary arterial hypertension, asthma, chronic obstructive pulmonary disease, and more. Our experts utilize advanced technologies, including fully equipped invasive and non-invasive systems, such as the pulmonary function test system, small animal whole-body plethysmography, and the resistance and compliance (RC) system.
Download our flyer to view our case studies, including bleomycin-induced pulmonary fibrosis and ovalbumin-induced asthma in mice.
Flyer_Pulmonary disease platform
Related Content
KRAS G12D inhibitors continue to advance, but treatment resistance remains an important challenge. Understanding how that resistance develops is critical...
VIEW RESOURCEMetabolic dysfunction-associated steatohepatitis (MASH) remains a significant global health challenge, driven by a complex interplay of lipid dysregulation, inflammation, and...
VIEW RESOURCE